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Abstract 
 
Peroxisome Proliferator-activated Receptors (PPARs) are ligand-inducible transcription 
factors, that can be activated by both dietary fatty acids and their metabolic derivates in the 
body, as by eicosanoids, hypolipidemic agents or antidiabetic drugs. To date three PPAR 
isotypes have been identified in mammals, birds, and amphibians, termed PPARα, PPARγ, 
and PPARβ/δ. Each isotype is a product of a separate gene and each one has a distinct 
tissue distribution . The importance of this receptors is nowadays a focus on different stu-
dies, due to medical and pharmacological interest, most studies on PPARs have concen-
trated on mammalian genes and proteins but also some research has also been done on fish. 
This recent interests on fish is due to the fact that aquaculture production is increasing and 
it's being a challenge feeding fish using fish oil, trying to replace it with vegetable oil. 
Changing the dietary pattern  influences the fatty acid composition in fish tissues with the 
decrease of the n-3 highly unsaturated fatty acids, as main consequence rendering fish less 
beneficial for human health. One way to find new approaches for using vegetable oil or 
other ways to feed farmed fish, is to study changes on gene expression, or on receptors that 
affect lipid's genome and one of those are PPARs.  
The main objective of this study is to learn  about PPAR, focusing on the tissue distribu-
tion of his different isotypes, and associate it with their functions on the organism. While   
studying the PCR methodology in order to know the gene expression of each PPAR.  
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Abbreviations 
  
 
PPAR Peroxisome Proliferator-activated Receptors 
CD36  Cluster of differentiation 36 
NHR Nuclear hormone receptor  
FA  Fatty acid 
PPRE  PPAR response element 
CPT1 Carnitine palmitoyltransferase 1  
SR-B1 Scavenger receptor class B member 1  
TZD Thiazolidinediones  
TG Triglycerides  
LDL Low-density lipoprotein  
HDL High-density lipoprotein  
LPL Lipoprotein lipase  
PUFA Polyunsaturated fatty acids  
ALA α-Linolenic acid  
LA Linoleic acid  
ARA Arachidonic acid  
EPA Eicosapentaenoic acid  
DHA Docosahexaenoic acid 
RT-PCR Reverse Transcription PCR 
qPCR Quantitative PCR 
PCR Polymerase chain reaction  
NTC No-template controls (NTCs 
miRNA MicroRNA 
NUOR NADH-ubiquinone oxidoreductase  
ETIF Eukaryotic translation initiation factor 3 
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1 Introduction 
 
1.1. PPAR definition 
Peroxisome Proliferator-activated Receptors (PPARs) are ligand-inducible tran-
scription factors belonging to the nuclear hormone receptor (NHR) superfamily. 
To date three PPAR isotypes have been identified in mammals, birds, and amphi-
bians, termed PPARα, PPARγ, and PPARβ/δ. Each isotype is a product of a sepa-
rate gene and each one has a distinct tissue distribution and, like typical sibling, 
are often functionally in disagreement with each other [5]. 
 
PPARs have been identified as targets for regulation by fatty acids or their meta-
bolites. Fatty acids (FAs) bind to and regulate the activity of PPARs. All PPARs 
bind 20-carbon polyunsaturated fatty acids, e.g. 20:4,n6 and 20:5,n3 (ω6 and ω3) 
[6]. They can be activated by both dietary fatty acids and their metabolic derivates 
in the body, and thus serve as lipid sensors which when activated can markedly 
redirect metabolism.  They are also activated by various natural and synthetic li-
gands like eicosanoids, hypolipidemic agents, and antidiabetic drugs [3] 
 
In terms of genomics for these receptors, transcriptional activation of target genes 
by PPARs requires the presence of peroxisome proliferator, or PPAR response 
elements (PPREs) in the promoter of target genes. The DNA consensus sequence 
for the PPRE is AGGTCAXAGGTCA, with X being a random nucleotide [9]. 
These PPREs are direct repeat elements of the DR1 type. PPARs bind as hetero-
dimers with the retinoid-X-receptor, conformational changes of the receptors li-
gand binding domain result in the release of corepressor proteins, recruitment of 
coactivator proteins, and subsequent assembly of protein complex that enhances 
transcription of the target gens [5]. 
A number of PPAR target genes have been characterized to date. Most of these 
genes are known to have roles in lipid and glucose metabolism, whereas PPAR 
ligands are themselves, in many cases, the substrates and/or products of the en-
zymes whose genes PPARs have emerged as critical regulators of lipid and glu-
cose homeostasis in mammals [5]. 
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Due to obvious medical and pharmacological interest, most studies on PPARs 
have concentrated on mammalian genes and proteins. But some research has also 
been done on fish.  Although differences in the genomic organization of the fish 
PPAR genes compared with their mammalian counterparts are evident, sequence 
alignments and phylogenetic comparisons show the fish genes to be homologs of 
mammalian PPARα, PPARβ, and PPARγ  [5]. 
 
All different subtypes of PPARs have been identified in Atlantic Salmon (Salmo 
salar L.). Four genes coding for four different subtypes of PPARβ have been iden-
tified, these subtypes were grouped into two families based on differences in exons 
and exon-flanking regions. Each subtype had a characteristic expression pattern 
varying between tissues. Furthermore, two forms of PPARγ been described in 
Atlantic salmon liver [9]. This kind of research has not been done just in Salmon, 
grass carp  (Ctenopharyngodon idella), brown trout (Salmo trutta), plaice (Pleuro-
nectes platessa) and gilthead sea bream (Sparus aurata) are other examples of 
cross-hairs.  
 
 
1.2. PPAR tissue distribution 
 
The three PPAR family members have distinct patterns of tissue distribution and 
consistent with their expression profiles, the PPARs each carry out unique func-
tions in the regulation of energy metabolism  
In mammals, PPARα is expressed in metabolically active tissues, e.g. the liver, 
and induces a range of genes involved in lipid transport, oxidation and thermoge-
nesis. PPARγ is found in white adipose tissues, where they are involved in lipid 
synthesis. PPARβ is abundantly expressed throughout the body markedly on 
brain, adipose tissue, and skin but at lows levels in liver, and has less defined func-
tions. [12]. 
 
A study about PPARs in grass carp (Ctenopharyngodon idella) found that PPARα  
predominates in the liver, as mammal PPARα does, PPARβ is widely expressed, 
particularly abundant in heart, liver and  muscle and PPARγ is abundant in the 
liver,  and to a lesser extent in brain,  muscle and  visceral adipose tissue [6] . Thus 
here we can find a coincidence between PPARα and PPARβ in humans and this 
fish. Another study about the brown trout (Salmo trutta f. fario), concluded that 
PPARα predominates in white muscle, heart and liver.  PPARβ is more expressed 
in testis, heart, liver, white muscle and trunk kidney, so throughout the whole fish, 
as humans and the other fish species do, and PPARy is found in trunk kidney and    
liver [1]. There is some research done on the plaice (Pleuronectes platessa) and 
the gilthead sea bream (Sparus aurata) affirming that in sea bream, PPARα is 
mostly expressed in liver and heart, and PPARγ in intestine and adipose tissue. 
PPARβ is expressed in all sea bream tissues, so as the others cases is the most 
widely expressed. In plaice, the PPAR expression profile is generally similar to 
sea bream. The major differences are the higher level of PPARβ over PPARα in 
liver and the low level of PPARα in red muscle [5]. 
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In these studies it is of interest to note that PPARy is widely expressed in different 
tissues at a level at least similar of PPARβ. This is in contrast to both mammals 
and amphibians where this isotype exhibits a restricted expression pattern, being 
present mainly in adipose tissue, and only at low level in most other tissues. But, 
like its mammalian homolog, fish PPARα is mostly expressed in tissues with high 
β-oxidation capacity, namely liver or heart. As PPARα does PPARβ has a similar 
distribution pattern in both, fish and mammals. 
 
1.3. The significance of PPAR in physiology and human diseases 
 
As said before, PPARs play a major role in whole body lipid and glucose metabol-
ism, as well as in inflammatory and immune responses. Based on in vitro binding 
and cell culture studies PPARs have emerged as prospective monitors of intracel-
lular non-esterified  FA levels, and in liver this receptors would respond accor-
dingly by altering metabolism to prevent lipid and cholesterol overload. [6] 
 
PPARα has been shown to activate the gene coding for the β-oxidation enzyme, 
carnitine palmitoyltransferase 1 (CPT1) by binding to a PPREs in the promoter 
region of the gene, thus playing an important role in regulating β-oxidation in ro-
dents, fish and humans. Others target genes on β-oxidation series for PPARα are 
genes coding for enzymes like Acyl-CoA oxidase, and hydroxyacyl dehydroge-
nase, or fatty acid binding proteins and transmembrane fatty acid trasnporters such 
as CD36 and FAT. Both PPARα and PPARγ have shown to induce the transcrip-
tion of the transmembrane fatty acid transporter CD36 and SR-B1. SR-B1 is a cell 
surface, high density lipoprotein receptor and a member of CD36 receptor family. 
It's expressed in all tissues engaged in cholesterol metabolism, and so this seems to 
be the reason for what PUFAs increase hepatic cholesterol uptake [9]. 
 
The PPAR activators correct the levels of plasma cholesterol and TGs, as a conse-
quence of glucose, and exert anti-inflammatory actions. As a consequence they 
appear good drug targets for the treatment of dyslipidemia, type 2 diabetes, and for 
the reduction of the progression of coronary atherosclerosis and so the decrease of 
the incidence of coronary heart disease. [2], [3] 
 
Nowadays, there is some pharmacological compounds that use them as targets. 
Fibrates are lipid lowering drugs that act through PPARα activation, and thiazoli-
dinediones (TZDs), a class of insulin sensitizers, are synthetic ligands for PPARγ. 
They have different effects because of the activation of different PPARs, due to 
the fact that they have different tissue distribution.   
Dyslipidemia associated with metabolic syndrome is characterized by elevated 
plasma levels of small dense low-density lipoprotein (LDL) and TGs and by re-
duced high-density lipoprotein (HDL) cholesterol levels. Fibrates, which are rela-
tively weak PPARα ligands, stimulate intravascular lipoprotein lipase (LPL) activ-
ity and reduced expression of apoCIII, a natural LPL inhibitor.  
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They also inhibit TG synthesis and very-low-density lipoprotein production by 
favoring FA uptake and retention, enhancing FA catabolism and reducing FA syn-
thesis in hepatocytes. As 
hypotriglyceridemic 
drugs, fibrates also in-
duce the expression of 
apoAV, an important 
determinant of plasma 
TG levels. Fibrates im-
prove LDL clearance by 
changing the plasma 
LDL distribution profile, 
from small dense to large 
LDL particles that dis-
play higher affinity for 
the LDL receptor. More-
over, fibrates stimulate 
the production of apoAI 
and apoAII in human 
liver, thus leading to 
increased HDL produc-
tion.  
             Figure 1. Functions of PPARα and PPARγ                                                                                                           
depending on their agonists. 
 
TZDs are PPARγ ligands that affect the levels of circulating free FAs and choles-
terol (by increasing the level of HDL cholesterol). Activation of PPARγ induces 
the expression of genes controlling adipocyte FA metabolism, including those that 
encode LPL and FA transport proteins, conducting to lypolisis of plasma TGs, 
uptake of FAs and storage of TGs in adipocytes. In addition, TZDs improve insu-
lin sensitivity by reducing peripheral insulin resistance and so they low blood glu-
cose levels in patients with type 2 diabetes. As a consequence, PPARγ activation 
reduce the release of free FAs and insulin-resistance-mediating adipocytokines, 
such as tumor necrosis factor (TNFα), leptin and resistin, and increase production 
of adiponectin, which has anti-atherosclerotic and anti-diabetic properties.  
 
There are new therapeutic approaches that are trying to find selective PPAR mod-
ulators, PPARγ antagonists, and combined PPARα and PPARγ agonists [2]. 
 
1.4. The importance of PPAR in salmon. 
 
It has been shown that dietary fat influence the gene expression by controlling the 
activity or abundance of central transcription factors, and one nuclear receptor that 
influences this transcription are PPARs. As said before PPARs can be activated by 
FA [9]. 
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There are two families of FA needed to be present in adequate and balanced quan-
tities within the human body for man to stay healthy. These two groups of FA are 
the omega-6 (n-6) and omega-3 (n-3) polyunsaturated fatty acids (PUFA). α-
Linolenic acid (ALA) is the key essential n-3 FA, and linoleic acid (LA) is the 
corresponding essential n-6 FA. Both of cannot be synthesized in higher verte-
brates including humans. The essential FA can be found in many different sources 
of food, especially in nuts, various plants, seeds and oils.  In the body, LA can be 
metabolized to its longer chain derivate, arachidonic acid (ARA), and ALA can be 
methabolized to eicosapentaenoic acid (EPA) and further on to docosahexaenoic 
acid (DHA). However, in 
most vertebrates, the 
ALA conversion to EPA 
or DHA is very limited. 
Fish and shellfish being 
naturally high in EPA 
and DHA are the most 
important source for the 
highly unsaturated n-3 
fatty acids. Furthermore, 
fish is naturally low in n-
6 FA and consequently 
generate a low n-6/n-3 
ratio, which is known to 
be beneficial for human 
health [9], [12]. 
 
Figure 2. Elongation and 
desaturation of n-6 and n-3 FA. 
 Adapted from (Voss et 
al.,1991) and modified after 
(Trattner, 2009) 
 
Despite that, meeting the dietary demands of a growing human population for 
balanced PUFA intake is actually a challenge. One way to meet this demand is 
through aquaculture of fish, such as salmon, tuna, sardines, trout etc. that all con-
tain high levels of n-3 long chain PUFAs and are low in n-6 FAs. Another way is 
to achieve a better understanding of the regulation of the PUFA metabolism by 
monitoring the underlying internal molecular mechanisms [9]. 
It's known that global production of fish from aquaculture has grown substantially 
with almost 10% per year over the past decades. Roughly 50% of fish used for 
human consumption are now farmed, and this proportion increases more every 
year [9]. This growth on aquaculture was made possible by the development of 
formulated fish feed including aminoacids, FAs, minerals and vitamins fulfilling 
all essential requirements. The diets have been relaying on fish meal and fish oil 
rich in n-3 PUFAs from natural fisheries to generate a diet high in both lipids and        
proteins [12]. 
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The development of aquaculture has been heavily depending on the availability of 
fish oil supply. Fish oil is basically made by pelagic fish, naturally high in both 
EPA and DHA. However the landings from global fisheries of pelagic fish cannot 
keep up with this increasing demand from the industrial aquaculture [9]. There-
fore, it has been an important cause for a lot of researches to find new lipid sources 
for fish feed. This investigations focus on finding a replacement of the fish oil with 
vegetable alternates, but doing it a decrease in long chain n-3 FA is noticed. 
Growth and fish health have been shown to not be negatively affect by replace-
ment of up to 50% of fish oil in the diet with vegetable oils, but more knowledge 
of the metabolic effects of these compounds is needed. And a way of understand-
ing this metabolism is to learn more about the effects on PPARs of different bioac-
tive compounds that can be added in this oils, as tocopherols, carotenoids, sterols, 
certain fatty acids, sesamin, lipoic acid and other lipophilic compounds [9],[12]. 
 
 
1.4. PCR methodology 
 
In order to quantify the gene expression of PPAR is necessary to understand the 
Polymerase chain reaction (PCR) method. PCR is a molecular biological technique 
used to amplify a specific region of a DNA strand, the DNA target, across several 
orders of magnitude, generating thousands to millions of copies of this particu-
lar DNA sequence. The versatility of PCR has brought a large number of variants, 
in this study we used two of them, the RT-PCR (Reverse Transcription PCR) and 
the qPCR (Quantitative PCR).  
 
qPCR or also called Real-time PCR has the ability to monitor the complete DNA 
amplification process of a target DNA molecule throughout the PCR reaction. It 
quantitatively measures amounts of  cDNA, it's used to determine whether a DNA 
sequence is present in a sample and the number of its copies, in other words, to 
quantify the gene expression of a molecule in the sample [14].  
After a correct setup, run and technical quality control of a qPCR the CT value 
must be determined [8].The CT is defined as the number of cycles needed for the 
fluorescence signal to reach a specific threshold level of detection and is inversely 
correlated with the amount of template nucleic acid present in the reaction. 
Another quality control is using reference genes, to compare their amplification 
with the sample genes. The accurate quantiﬁcation of a true reference gene allows 
the normalisation of diﬀerences in the amount of ampliﬁable cDNA in individual 
samples generated by diﬀerent amounts of starting material, the quality of the star-
ting material; and diﬀerences in RNA preparation and cDNA synthesis, since the 
reference gene is exposed to the same preparation steps as the gene of  
interest [7]. The use of no-template controls (NTCs)  in qPCR runs is also requi-
red. NTCs are controls where water instead of DNA is included in the reaction 
mixture; this checks for purity of the PCR components. Moreover, they are neces-
sary to check the proper function of the primers used on the PCR, to control the 
bindings to each other [8].  
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2 Materials and Methods 
 
 
3.1. Fish 
 
Atlantic salmon of approximately 10g (Älvkarleby Research Station, Älvkarleby, 
Sweden) was kept in tanks with water from the river “Dalaälven” at 10°C and fed 
a commercial diet (Alleraqua Performa pellet size 2 and 9% fat content, Aller 
Aqua A/S, Christiansfeld, Denmark) prior to sampling [13]. 
 
 
3.2.  mRNA and miRNA extraction 
 
The interest of this study is to analyze different samples of RNA from different 
tissues of Atlantic Salmon, therefore an extraction of miRNA was done from white 
muscle, intestine, gill, kidney, brain, liver, stomack, heart, spleen, and red muscle 
from a salmon fish. Three different samples from three different individuals were 
taken from this tissues. A summary of the samples are shown in Table 1. The tis-
sue samples used for miRNA analysis were collected and transferred to RNA later 
(Life Technologies, Carlsbad, CA, US) and stored at – 80°C until further analysis 
[13]. 
 
These  miRNA samples were isolated with mirVana™ PARIS™ Kit. The tissue 
samples were disrupted in Cell Disruption Buffer. For RNA isolation, the lysate 
was mixed with 2X Denaturing Solution and subjected to Acid-Phenol:Chloroform 
extraction which provides a robust front-end RNA purification that also removes 
most DNA. Then, the RNA was purified adding Etanol to the samples, and they 
were passed through a Filter Cartridge containing glass-fiber which immobilizes 
the RNA. The filter was then washed a few times, and finally the RNA was eluted 
with a low ionic-strength solution.  
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3.3. RT-PCR 
 
The gene expression on these tissue samples was investigated by quantitative 
Real-Time PCR. The first step on this procedure was analyze the exact concentra-
tion of RNA that the samples contained in order to know the volume to use in the 
RT-Reaction, this have been done using an spectrophotometer and the results are 
shown in Table 1.  
After diluting the less concentrated samples (20 to 28), samples not present in 
triplicates were excluded from the study (8,17,19, 29), the total RNA was quanti-
fied and reverse transcription First strand cDNA was synthesized using the High 
Capacity RNA-to-cDNA™ Kit.  
So we mixed our samples with the RT Buffer and the RT enzyme mix that con-
tains the kit, in 20 µL aliquots and ran them in the adequate thermal cycler condi-
tions using an special thermal cycler.  
 
 
 
                    
Tissues 
 
RNA  concentrations 
(µg/µl) 
1. White muscle 1 0.038 
2. Intestine 1 0.023 
3. Gill 1 
 
0.015 
4. Kidney 1 
 
0.018 
5. Brain 1 
 
0.044 
6. Liver 1 
 
0.015 
7. Stomach 1 0.031 
8. Heart 1 
 
Discarded 
9. Spleen 1 
 
0.015 
10. White muscle 2 0.017 
11. Intestine 2 0.019 
12. Gill 2 
 
0.014 
13. Kidney 2 
 
0.033 
14. Brain 2 
 
0.036 
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15. Liver 2 
 
0.046 
16. Stomach 2 0.034 
17.  Heart 2 
 
Discarded 
18. Spleen 2 
 
0.329 
19. Red muscle 2 Discarded 
20. White muscle 3 0.274 
21. Intestine 3 1.455 
22. Gill 3 
 
0.854 
23. Kidney 3 
 
0.992 
24. Brain 3 
 
0.307 
25. Liver 3 
 
2.154 
26.  Stomach 3 2.538 
27. Not extracted 
 28.  Spleen 3 
 
0.162 
29.  Red muscle 3 Discarded 
Table 1. Samples and RNA concentrations to run on RT-PCR 
 
 
3.4. PCR (cDNA synthesis) 
 
At this point we had the samples of RNA converted to cDNA. The PCR reactions 
were run on plates on an Applied Biosystems real-time quantitative PCR instru-
ment, in 20 µL reaction volumes.  
In order to analyze the gene expression of PPARs in every tissue we used  the Fast 
SYBR® Green Master Mix and performed a quantitative real-time PCR in our 
samples. 
Therefore, we used 5 different primers to obtain 5 different genes. The primers 
were designed based on available Atlantic salmon sequences from the online ver-
sion of GenBank® (NCBI) using Primer Express® software or copied from litera-
ture references and custom-made at Invitrogen Part of Life Technologies 
(Carlsbad, CA, USA) [11]. The two reference genes used were NADH-ubiquinone 
oxidoreductase (NUOR) and Eukaryotic translation initiation factor 3 (ETiF) [9].  
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The other genes that were looked for the study were the genes coding for PPARα, 
PPARβ and PPARγ. We mixed the primers with our samples, and the Fast 
SYBR® Green Master Mix that contains uracil-DNA glycosylase for preventing 
the reamplification of carryover PCR products.  
 
 
3.4. qPCR 
 
In order to know the dilutions to be used for qPCR analysis the first plate was ran 
with different dilutions, but the results showed better values with the non diluted 
ones. The PCR products without dilutions were used directly in the analysis, with-
out doing the dilutions, and we ran the first two plates with the first 6 samples for 
each gene in triplicate with three non-template control, using   2 µL of each sam-
ple. A melt curve was performed after each run in order to control for primer-
primer bindings and in samples with 2µl cDNA the CT-value was too high. In 
order to optimize the results, we changed our method, and used 6 µL of each sam-
ple, but we didn't have enough sample to run them in triplicate, so we decided to 
run them alone, with non repeated cDNA samples, even if this means that the re-
sults could be less statistically significant.  
 
 
3.6. Data evaluation 
 
 In order to evaluate the data from gene expression we viewed the amplification 
plots, adjusted the baseline and threshold values to determine the threshold cycles 
(CT) for the amplification curves.  An statistical analysis with DataAssist ™ ver-
sion 3.0.  was made to compare the  relative quantitation of gene expression in the 
different tissues. This data analysis tool for sample comparison uses the compara-
tive CT (ΔΔCT). So, the CT of PPARs gene expression were compared and this 
way, decided where they are more or less expressed. 
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3 Results 
 
The relative expression of PPARs was compared with the expression showed in 
liver. So, the results obtained using the liver as reference group are shown in dif-
ferent graphics below.  
 
   
 
 
 
 
 
 
 
 
Figure 3. Relative gene expression of the three types of PPAR in different tissues, compared to the 
liver. In order to understand better the values, some of them were discarded, as PPARα in gill, 
PPARα in spleen, and PPARγ in white muscle 
PPARα is the most expressed type, in fact the value of the relative expression on 
gill compared to the liver was 21151.08, far exceeding all other values, being 
those close to 1. Something similar happened with the spleen value for PPARα, 
that was 33.7423. On white muscle and brain also the values for this PPAR are 
quite high, at least the expression is higher than the one in the liver.  
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PPARβ shows a remarkable higher expression in the brain than in  the liver, and 
it's also a higher value to consider the one in the stomach, having the spleen the 
same value, the other tissues show lower ones. 
PPARγ showed a similar problem as PPARα, being this higher expressed in white 
muscle, the exact value of the relative expression was 6.7571. The results show 
too that the most gene expression seems to be in the liver, as the other values are 
totally lower.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4                                                                             Figure 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6                                                                               Figure 7 
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Figure 8                                                                                 Figure 9 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 
As we can see in the previous graphics, each tissue has a different distribution of 
each PPAR. In gill, and spleen the PPARα is most widely expressed with differ-
ence from the other tissues. In intestine PPARα is also the most expressed, but 
PPARγ and PPARβ have also a remarkable value of expression. The kidney is the 
other organ where we can see that PPARα has the most expression, but in this case 
PPARγ is close to his value, and PPARβ has a really low value in comparison.  
In brain and stomach we can see that PPARβ is the main character, and also 
PPARγ the less expressed. White muscle is the only one where PPARγ is widely 
expressed, and hasn't got any PPARβ expression, or at least not a remarkable one.  
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Figures 4,5,6,7,8,9,10. Relative 
expressions of the three types of 
PPAR in each analyzed tissue, 
compared to the liver.  
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4 Discussion 
 
The main objective of this study was to investigate the gene expression of the 
three different types of PPAR (α,β,γ) in some tissue samples of the Atlantic Sal-
mon, as to learn about the methodology to do it, focusing on PCR method. 
The results were quite difficult to evaluate, due to the fact that just one replicate of 
each sample has been analyzed with the quantitative real-time PCR, so in this re-
search some points are remarkable to consider, but not all are totally agree with the 
literature. 
Some explanation about the difficulty to obtain results in this project work could 
be the weaknesses of PCR such as the low quantities of DNA that are required, 
thus the need of accurate manipulation of them. Also, the concentration of DNA 
samples may be optimized, so they can be finished, then having the possibility of 
not being able to get more amount of sample to continue the development of more 
plates. This is what exactly happened in this experiment, we couldn't use more 
than one replicate because the samples were run out. Also when using a PCR if the 
requirement is amplify a specific gene, some knowledge of the gene's DNA se-
quence is needed, in order to design some primers, therefore the need of having 
good primers is important to notice, they cannot bind to each other and they have 
to work properly to obtain the gene expression. 
The relative expression of PPARs was compared with the expression showed in 
liver, as is one tissue that for sure presents PPAR activity, being one tissue with 
more metabolically activity, as high β-oxidation capacity [8]. About the results 
obtained we could evaluate that PPARα is supposed to be found in tissues that 
catabolize large amounts of fatty acids, at least in metabolically actives tissues 
[12]. However, the most expression was found in the gill, and the other tissues 
where is widely expressed are spleen, kidney and intestine. So, maybe in this point 
the literature is not totally agree with the results. It's important to say also that the 
most expressed isotype was this PPARα. 
PPARβ is supposed to be widely expressed on the whole animal, and some litera-
ture reflects that is markedly found on brain, adipose tissue and skin in mammals, 
and also in some fishes [5], [12].Thus our results on this isotype are the most simi-
lar ones, because we could find PPARβ in most of the tissues, except the white 
muscle, being the brain the most representative one.  
 
20 
 
 
The widespread distribution of PPARβ could indicate that it plays several roles in 
cell physiology, including basic lipid  metabolism, epidermal cell proliferation and 
differentation, adipocyte function and placentogenesis [5].  
PPAR𝛾 has been the most tricky sample to analyze, being always the results of 
this one a little bit difficult to trust. However, the other fishes literature explain the 
fact that it's widely expressed in the whole fish, being this a difference with mam-
mals, where we can find it being present mainly in adipose tissue, and only at low 
level in most other tissues. Being the major functions of PPARγ  to induce adipo-
genesis and  affect  the  storage of fatty  acids [5]. Therefore, in our fish we didn't 
analyze adipose tissue, so it could be an explanation of why the expression of 
PPARγ was difficult to find in the other tissues.  
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